RNAimmune Competitors and Similar CompaniesClear all
Uvax Bio's competitors and similar companies include Stemirna and CureVac.
 Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. | |||
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2000 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Wilmington, US HQ | Locations Shanghai, CN HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 1110% increase | Employees N/A | Employees 82517% decrease |
Operating ⚠ | |||
Patent Applications | Patent Applications N/A | Patent Applications 2 (May, 2020) | Patent Applications 500 (Mar, 2020) |
Patents Issued | Patents Issued 1 (May, 2020) | Patents Issued 2 (May, 2020) | Patents Issued 233 (May, 2020) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 206.5m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company